我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

抗血小板药物对冠心病支架植入术后再狭窄防治效果的观察(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2004年第5期
页码:
459-461
栏目:
临床研究
出版日期:
2004-09-01

文章信息/Info

Title:
Effect of antiplatelet drugs on the incidence of restenosis after percutaneous transluminal coronary angioplasty and in-stent implantation
作者:
张莉莉;  贾国良;  王海昌; 郭文怡;  马兰香;  孙玉波
第四军医大学西京医院心内科,陕西西安710032
Author(s):
ZHANG Li-li ;  JIA Guo-liang ;  WANG Hai-chang ;  GUO Wen-yi ;  MA Lan-xiang ;  SUN Yu-bo
Department of Cardiovasology , Xijing Hospital , Fourth MilitaryMedical University , Xi’an , Shaanxi 710032 , China
关键词:
血管成形术; 经腔; 经皮; 冠状动脉; 再狭窄; 抗血小板药物; 抗凝
Keywords:
angioplasty ; transluminal ; percutaneous ;  coronary ;  restenosis ;  antiplatelet drugs ;  anticoagulation
分类号:
R543. 31
DOI:
-
文献标识码:
A
摘要:
目的: 观察冠状动脉介入治疗术术前应用不同抗血小板药物对血中血小板活性、功能、凝血功能和术后半年 再狭窄发生的影响。方法:行经皮腔内冠状动脉成型术及支架植入术(PCI) 治疗的冠心病患者826 例,按术前服用 抗血小板药物种类和服用时间分为3 组,第1 组( n = 383) 为术前3 d 服用阿斯匹林0. 3 g + 抵克力得250 mg。第2 组( n = 356) 为术前3 d 服用阿斯匹林0. 3 g + 氯比格雷75 mg。第3 组( n = 87) 为急诊PCI 术前2 h ,服用阿斯匹林 0. 3 g + 氯比格雷300 mg ,从上述3 组中各随机抽取30 例患者,于PCI 术前采血。采用TXYM-91 型血小板聚集仪测 定血小板最大聚集率(MPAR) ,双抗夹心法(ELISA) 测定血小板α颗粒膜蛋白(GMP2140) 及血栓烷B2 (TXB2) 的浓度。 随访826 例患者再狭窄发生的情况。结果:服用阿斯匹林+ 氯比格雷血中血小板活性、功能及凝血功能优于服用阿 斯匹林+ 抵克力得。术后半年第3 组与第2 组PCI 术后再狭窄发生率显著低于第一组( P < 0. 01) 。结论:术前服用 阿斯匹林+ 氯比格雷的疗效较好,预防再狭窄安全有效。
Abstract:
AIM: To assess the effects of different antiplatelet drugs given before the percutaneous transluminal coronary angioplasty and in-stent implantation (PCI) on platelet ’s character and cruor function to restenosis a half year after the operation. METHODS: 826 patients with coronary heart disease who had undergone PCI were divided into 3 groups according to the administration of different antiplatelet drugs and at different times before PCI. The first group ( n = 383) patients took Ticlopidine 250 mg/ d ,Aspirin 0. 3 g/ d continulously and were phlebotomized 3 days later. The second groups( n = 356) patients took Clopidogrel 75 mg/ d , Aspirin 0. 3 g/ d continulously and were phlebotomized 3 days later. The third group ( n = 87) patients took Clopidogrel 300 mg bolus , Aspirin 0. 3 g and were phlebotomized 2 hours later. From each group 30 patients were chosen at random. They were all phlebotomized before PCI. MPARs (Maximal Platelet Aggregation Rate) were determined by using enhanced turbidity. The plasma levels of GMP2140 and TXB2 were measured by ELISA. 826 patients were followed up for restenosis. RESULTS : Platelet ’s character and cruor function of the patients given Clopidogrel were better than those of the patients given ticlopidine. A half year after the operation ,the incidences of restenosis in the third and the second group were lower than in the first one. CONCLUSION: Effect of Clopidogrel and Aspirin 3 dags before PCI is better than that of any other antiplatelet drug. It is safe and feasible in the prevention of in-stent restenosis.

参考文献/References

[1 ] 田建伟,赵连友,郑强荪. PTCA 术后再狭窄机制的研究现状[J ] .心脏杂志,2002 ,14(4) :353 - 355.

[2 ] 肖文良,毛节明. 急性冠状动脉综合征的介入治疗进展[J ] . 心脏杂志,2002 ,14(3) :264 - 266.

[3 ] Dehmer GJ ,Nichols TC , Bode AP , et al . Assessment of platelet activation by coronary sinus blood sampling ballon angioplasty and directional coronary atherectomy[J ] . Am J Cardiol , 1997 ,80(7) :871 - 877.

[4 ] Hanke H , Strohschneider T , Oberhoff M, et al . Time course 0f smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty[J ] . Circ Res , 1990 ,61 :651 - 659.

[5 ] Gregorini L , Marco J , Fajadet J , et al . Ticlopidine and aspirin pretreareatment reduces coagulation and platelet activation during coronary dilation proceduries[J ] . J Am Coll Cardiol , 1997 ,29(1) :13 - 20.

[6 ] Herbert MJ , Frehel D ,Vallee E , et al . Clopidogrel , a novel antiplatelet and antithrombotic agent [J ] . Cardiovasc Drug Rev , 1993 ,11 (2) :180 -198.

[7 ] Steinhubl SR ,Tan WA , Foody JM, et al . Incidence and clinical course of thrombocytopenic purpura due to ticlopidine following coronary stenting [J ] . JAMA , 1999 , 281 (9) :806 - 810.

[8 ] Bennett CL , Davidson CJ , Raisch DW, et al . Thrombotic thrombocy-topenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention [ J ] . Arch Intern Med , 1999 , 159 (21) :2524 - 2528.

备注/Memo

备注/Memo:
收稿日期：2004-1-9
更新日期/Last Update: 2004-09-01